Asia Pacific In-Vitro Fertilization Market Growth, Size, Trends, Share, Revenue and Future Outlook: SPER Market Research

Q: How can I get a sample report on the Asia-Pacific In-Vitro Fertilization (IVF) Market?

You can get the sample pages by clicking the link - Click Here

Published: Feb 2024	Report ID: HLCA2424	Pages: 1 - 154	Formats^*:
Category : Healthcare

Asia-Pacific In-Vitro Fertilization (IVF) Market Introduction and Overview

According to SPER Market Research, the Asia-Pacific In-Vitro Fertilization (IVF) Market is estimated to reach USD 63.52 Billion by 2033 with a CAGR of 17.24%.

The report includes an in-depth analysis of the Asia-Pacific In-Vitro Fertilization (IVF) Market, including market size and trends, product mix, applications, and supplier analysis. An assisted reproductive technology (ART) process called in vitro fertilisation (IVF) involves fertilising egg cells with sperm outside of the woman's body and then implantation of the resulting embryo(s) into the uterus. This procedure helps with conception by addressing genetic or reproductive problems. It includes the collection of sperm and egg cells, followed by a manual combining process in a lab to create embryos. After that, the uterus receives these embryos to continue their development. IVF is frequently used to help individuals and couples, including LGBT people, single mothers, and those who are struggling with infertility.

In March 2020: In order to educate infertile couples about medical advancements, Gurugram Hospital launched a Specialised Infertility Programme and Awareness Campaign. The programme involves sharing IVF success stories with the public, demonstrating how the availability of cutting-edge technology is assisting couples in embracing motherhood.

In 2020: Vit Kit-NX is a vitrification medium solution that Fujifilm Irvine Scientific introduced with the goal of protecting embryos and achieving excellent survival rates. Thus, it is projected that the market will develop as a result of an increase in product approvals, product launches, and partnerships for IVF services.

Asia-Pacific In-Vitro Fertilization (IVF) Market

Market Opportunities and Challenges

Rising acceptability of IVF procedures, rising IVF success rates, and rising public knowledge of IVF procedures are the main factors driving the growth of the worldwide Asia-Pacific IVF services market. With further technological advances, the success rate of in vitro fertilisation is increasing. Pre-implantation genetic diagnosis (PGD), intracytoplasmic sperm injection (ICSI), and in vitro maturation (IVM), among other cutting-edge IVF procedures, have contributed to higher pregnancy success rates. It is projected that IVF treatments in India will be driven by decreased costs, a looser fertility regulation, and an increased age restriction. Moreover, people choose to fly to Asia, where donor egg IVF is permitted, while donor egg IVF services are not offered in certain nations, such as Germany and Italy. As a result, patients choose less expensive fertility destinations, opening up opportunities for expansion for the Asia-Pacific IVF services industry.

However, the use of IVF services is restricted by side effects of the therapy, such as multiple pregnancies and birth problems. The number of embryos transferred determines the success percentage of IVF and can result in multiple pregnancies. Multiple pregnancies can lead to difficulties such as high blood pressure and delivery-related issues. Additionally, a kid may experience a number of health issues as a result of numerous pregnancies, including low birth weight and early delivery. Furthermore, ectopic pregnancy—a condition in which the embryo implants outside of the woman's womb and poses a threat to her life—is another possible risk of IVF treatment. These issues restrict the uptake of IVF operations, which impedes the expansion of the market.

Get more information on this report: Download Free Sample PDF

Market Competitive Landscape

In vitro fertilisation (IVF) clinics, technology companies, and healthcare providers of all stripes compete in the Asia-Pacific IVF market by providing IVF services and solutions. The major key players in the Asia-Pacific In-Vitro Fertilization (IVF) Market are: Alcon, Bausch Health Companies Inc., Carl Zeiss AG, Cooper Companies, Johnson & Johnson, MaxiVision Eye Hospital, Rayner Surgical Group Limited, Schwind eye-tech-solutions GmbH & co.kg., STAAR Surgical Company, Ziemer Group AG, Others. A number of variables, including success rates, available technology, cost, and patient experience, influence competition.

Scope of the Report:

Report Metric	Details
Market size available for years	2019-2033
Base year considered	2022
Forecast period	2023-2033
Segments covered	By Cycle Type, By End User
Regions covered	Australia, China, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Rest of Asia-Pacific
Companies Covered	Alcon, Bausch Health Companies Inc., Carl Zeiss AG, Cooper Companies, Johnson & Johnson, MaxiVision Eye Hospital, Rayner Surgical Group Limited, Schwind eye-tech-solutions GmbH & co.kg., STAAR Surgical Company, Ziemer Group AG, Others

COVID-19 Impact on Asia-Pacific In-Vitro Fertilization (IVF) Market

The Asia-Pacific IVF services industry is expected to grow more slowly as a result of the COVID-19 pandemic. Numerous nations implemented lockdowns at the national level, which had a direct effect on fertility tourism as a result of aircraft delays, travel restrictions and quarantines, cancellation of all indoor and outdoor events, and emergency declarations. A great deal of clinics and hospitals underwent structural changes in order to accommodate more COVID-19 patients. Due to doctors' direct interaction with patients seeking IVF therapy, non-urgent patient visits to fertility clinics were discouraged, and elective fertility treatments were delayed. These elements therefore caused the cancellation of numerous planned IVF treatments and were predicted to impede the expansion of the Asia-Pacific IVF market throughout the pandemic.

Key Target Audience

Fertility Clinics and Centers
Pharmaceutical Companies
Medical Device Manufacturers
Hospitals and Clinics
Research Institutions
Others

Our in-depth analysis of the Asia-Pacific In-Vitro Fertilization (IVF) Market includes the following segments:

By Cycle Type:	Donor Egg IVF Cycle Fresh Cycle (Non-Donor) Thawed IVF Cycle (Non-Donor)
By End User:	Clinical Research Institutes Fertility Clinics Hospitals Surgical Centers
By Region:	Australia China India Indonesia Japan Malaysia Myanmar New Zealand Philippines Singapore South Korea Thailand Vietnam Rest of Asia-Pacific

Key Topics Covered in the Report

Asia-Pacific In-Vitro Fertilization (IVF) Market Size (FY’2023-FY’2033)
Overview of Asia-Pacific In-Vitro Fertilization (IVF) Market
Segmentation of Asia-Pacific In-Vitro Fertilization (IVF) Market By Cycle Type (Donor Egg IVF Cycle, Fresh Cycle, Thawed IVF Cycle)
Segmentation of Asia-Pacific In-Vitro Fertilization (IVF) Market By End User (Clinical Research Institutes, Fertility Clinics, Hospitals, Surgical Centers)
Statistical Snap of Asia-Pacific In-Vitro Fertilization (IVF) Market
Expansion Analysis of Asia-Pacific In-Vitro Fertilization (IVF) Market
Problems and Obstacles in Asia-Pacific In-Vitro Fertilization (IVF) Market
Competitive Landscape in the Asia-Pacific In-Vitro Fertilization (IVF) Market
Impact of COVID-19 and Demonetization on Asia-Pacific In-Vitro Fertilization (IVF) Market
Details on Current Investment in Asia-Pacific In-Vitro Fertilization (IVF) Market
Competitive Analysis of Asia-Pacific In-Vitro Fertilization (IVF) Market
Prominent Players in the Asia-Pacific In-Vitro Fertilization (IVF) Market
SWOT Analysis of Asia-Pacific In-Vitro Fertilization (IVF) Market
Asia-Pacific In-Vitro Fertilization (IVF) Market Future Outlook and Projections (FY’2023-FY’2033)
Recommendations from Analyst

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source

2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s

2.2. Market size estimation

2.2.1. Top-down and Bottom-up approach

2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis

4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges

4.2. COVID-19 Impacts of the Asia-Pacific In-Vitro Fertilization (IVF) Market

5. Market variable and outlook

5.1. SWOT Analysis

5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats

5.2. PESTEL Analysis

5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape

5.3. PORTER’s Five Forces

5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry

5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Asia-Pacific In-Vitro Fertilization (IVF) Market

7. Asia-Pacific In-Vitro Fertilization (IVF) Market, By Cycle Type (USD Million)

7.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Value Share and Forecast, By Cycle Type, 2023-2033
7.2. Donor Egg IVF Cycle
7.3. Fresh Cycle (Non-Donor)
7.4. Thawed IVF Cycle (Non-Donor)

8. Asia-Pacific In-Vitro Fertilization (IVF) Market, By End User (USD Million)

8.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Value Share and Forecast, By End User, 2023-2033
8.2. Clinical Research Institutes
8.3. Fertility Clinics
8.4. Hospitals
8.5. Surgical Centers

9. Asia-Pacific In-Vitro Fertilization (IVF) Market Forecast, 2019-2033 (USD Million)

9.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share

10. Asia-Pacific In-Vitro Fertilization (IVF) Market, By Cycle Type, 2019-2033 (USD Million)

10.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2019-2026)
10.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By Cycle Type (2027-2033)

11. Asia-Pacific In-Vitro Fertilization (IVF) Market, By End User, 2019-2033 (USD Million)

11.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By End User (2019-2026)
11.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By End User (2027-2033)

12. Asia-Pacific In-Vitro Fertilization (IVF) Market, By Region, 2019-2033 (USD Million)

12.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2019-2026)
12.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Size and Market Share By Region (2027-2033)
12.3. Australia
12.4. China
12.5. India
12.6. Indonesia
12.7. Japan
12.8. Malaysia
12.9. Myanmar
12.10. New Zealand
12.11. Philippines
12.12. Singapore
12.13. South Korea
12.14. Thailand
12.15. Vietnam
12.16. Rest of Asia-Pacific

13. Company Profile

13.1. Alcon

13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments

13.2. Bausch Health Companies Inc.

13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments

13.3. Carl Zeiss AG

13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments

13.4. Cooper Companies

13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments

13.5. Johnson & Johnson

13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments

13.6. MaxiVision Eye Hospital

13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments

13.7. Rayner Surgical Group Limited

13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments

13.8. Schwind eye-tech-solutions GmbH & co.kg.

13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments

13.9. STAAR Surgical Company

13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments

13.10. Ziemer Group AG

13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments

13.11. Others

14. List of Abbreviations

15. Reference Links

16. Conclusion

17. Research Scope

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Frequently Asked Questions About This Report

How big is the Asia-Pacific In-Vitro Fertilization (IVF) Market?

Asia-Pacific In-Vitro Fertilization (IVF) Market is projected to reach USD 63.52 billion by 2033, growing at a CAGR of 17.24% during the forecast period.

What is the growth rate of the Asia-Pacific In-Vitro Fertilization (IVF) Market?

Asia-Pacific In-Vitro Fertilization (IVF) Market grew in Market size from 2022. The Market is expected to reach USD 63.52 billion by 2033, at a CAGR of 17.24% during the forecast period.

What is the anticipated CAGR of the Asia-Pacific In-Vitro Fertilization (IVF) Market?

Asia-Pacific In-Vitro Fertilization (IVF) Market CAGR of 17.24% during the forecast period.

How can I get a sample report on the Asia-Pacific In-Vitro Fertilization (IVF) Market?

You can get the sample pages by clicking the link - Click Here

What is the Market size of the Asia-Pacific In-Vitro Fertilization (IVF) Market?

Asia-Pacific In-Vitro Fertilization (IVF) Market size is USD 63.52 billion from 2023 to 2033.

Which segment is expected to Asia-Pacific In-Vitro Fertilization (IVF) Market?

Asia-Pacific In-Vitro Fertilization (IVF) Market Segment is covered By Cycle Type, By End User.

Which region is expected to have the highest Market share in the Asia-Pacific In-Vitro Fertilization (IVF) Market?

The Asia-Pacific is anticipated to have the highest Market share in the Asia-Pacific In-Vitro Fertilization (IVF) Market.

Who are the key players in Asia-Pacific In-Vitro Fertilization (IVF) Market?

The key players in the Market include Companies Covered Alcon, Bausch Health Companies Inc., Carl Zeiss AG, Cooper Companies, Johnson & Johnson, MaxiVision Eye Hospital, Rayner Surgical Group Limited, Schwind eye-tech-solutions GmbH & co.kg., STAAR Surgical Company, Ziemer Group AG, Others.

What is the conclusion of the Asia-Pacific In-Vitro Fertilization (IVF) Market?

An assisted reproductive technology (ART) process called in vitro fertilisation (IVF) involves fertilising egg cells with sperm outside of the woman's body and then implantation of the resulting embryo(s) into the uterus.